Shares of Medidata Solutions Inc. (NASDAQ:MDSO) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $55.36 and last traded at $54.99, with a volume of 163,463 shares traded. The stock had previously closed at $53.77.

MDSO has been the topic of a number of recent research reports. Wells Fargo & Co. lowered shares of Medidata Solutions from an “outperform” rating to a “market perform” rating in a research note on Thursday, July 21st. Needham & Company LLC initiated coverage on shares of Medidata Solutions in a research note on Monday, July 11th. They set a “buy” rating and a $55.00 price target on the stock. Morgan Stanley reiterated a “buy” rating on shares of Medidata Solutions in a research note on Friday, June 10th. KeyCorp reiterated a “buy” rating on shares of Medidata Solutions in a research note on Thursday, July 7th. Finally, Zacks Investment Research upgraded shares of Medidata Solutions from a “hold” rating to a “buy” rating and set a $51.00 price target on the stock in a research note on Friday, April 29th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the stock. Medidata Solutions has a consensus rating of “Buy” and a consensus price target of $51.70.

The stock’s 50-day moving average price is $51.87 and its 200 day moving average price is $43.65. The firm has a market capitalization of $3.00 billion and a PE ratio of 138.89.

Medidata Solutions (NASDAQ:MDSO) last issued its quarterly earnings results on Wednesday, July 20th. The company reported $0.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.23 by $0.01. During the same period in the previous year, the business posted $0.22 earnings per share. The business earned $114.60 million during the quarter, compared to analyst estimates of $112.39 million. The firm’s quarterly revenue was up 16.8% on a year-over-year basis. On average, analysts anticipate that Medidata Solutions Inc. will post $1.01 EPS for the current fiscal year.

In other Medidata Solutions news, EVP Eileen Schloss sold 10,644 shares of the firm’s stock in a transaction dated Tuesday, July 26th. The stock was sold at an average price of $52.82, for a total value of $562,216.08. Following the sale, the executive vice president now directly owns 25,765 shares of the company’s stock, valued at approximately $1,360,907.30. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, President Vries Glen Michael De sold 7,500 shares of the firm’s stock in a transaction dated Tuesday, August 9th. The stock was sold at an average price of $54.39, for a total value of $407,925.00. Following the completion of the sale, the president now directly owns 982,653 shares in the company, valued at $53,446,496.67. The disclosure for this sale can be found here.

An institutional investor recently raised its position in Medidata Solutions stock. Principal Financial Group Inc. boosted its position in Medidata Solutions Inc. (NASDAQ:MDSO) by 3.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 372,108 shares of the company’s stock after buying an additional 12,610 shares during the period. Principal Financial Group Inc. owned 0.69% of Medidata Solutions worth $18,341,000 as of its most recent filing with the SEC.

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Medidata Clinical Cloud provides a platform of technology and data analytics solutions designed to manage activities across clinical development.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.